These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3281243)

  • 1. [Bone loss during aging or how one becomes osteoporotic?].
    Kuntz D
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):51-7. PubMed ID: 3281243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of modelling and remodelling on human vertebral body architecture.
    Mosekilde L
    Technol Health Care; 1998 Dec; 6(5-6):287-97. PubMed ID: 10100932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histomorphometry. Method for evaluating the bone mass].
    Meunier PJ; Chavassieux P
    Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):669-73. PubMed ID: 4095470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
    Parfitt AM; Mathews CH; Villanueva AR; Kleerekoper M; Frame B; Rao DS
    J Clin Invest; 1983 Oct; 72(4):1396-409. PubMed ID: 6630513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On aging bone loss.
    Mazess RB
    Clin Orthop Relat Res; 1982 May; (165):239-52. PubMed ID: 7075066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microanatomy of trabecular bone in young normal and osteoporotic elderly males.
    Shahtaheri SM
    Aging Male; 2007 Jun; 10(2):71-5. PubMed ID: 17558971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of ovariectomy on the mechanical properties of cortical and cancellous bone in rat femora and vertebrae.
    Chachra D; Lee JM; Kasra M; Grynpas MD
    Biomed Sci Instrum; 2000; 36():123-8. PubMed ID: 10834220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
    Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
    Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-level failure accumulation in vertebral cancellous bone: a theoretical model.
    Slomka N; Diamant I; Gefen A
    Technol Health Care; 2008; 16(1):47-60. PubMed ID: 18334787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth and age-related origins of bone fragility in men.
    Seeman E
    Calcif Tissue Int; 2004 Aug; 75(2):100-9. PubMed ID: 15383923
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and investigational approaches for reversing established osteoporosis.
    Kimmel DB; Slovik DM; Lane NE
    Rheum Dis Clin North Am; 1994 Aug; 20(3):735-58. PubMed ID: 7984787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model.
    Phillips FM; Turner AS; Seim HB; MacLeay J; Toth CA; Pierce AR; Wheeler DL
    Spine J; 2006; 6(5):500-6. PubMed ID: 16934718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mass, size and previous fractures as predictors of prospective fractures in an osteoporotic referral population.
    Eklund F; Nordström A; Björnstig U; Nordström P
    Bone; 2009 Oct; 45(4):808-13. PubMed ID: 19573633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis. Methods to prevent fractures in patients at high risk.
    Watts NB
    Postgrad Med; 1994 Apr; 95(5):73-4, 77-9, 83-8. PubMed ID: 8153049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in men--consensus is premature.
    Seeman E; Bianchi G; Adami S; Kanis J; Khosla S; Orwoll E
    Calcif Tissue Int; 2004 Aug; 75(2):120-2. PubMed ID: 15185060
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging views about "osteoporosis", bone health, strength, fragility, and their determinants.
    Frost HM
    J Bone Miner Metab; 2002; 20(6):319-25. PubMed ID: 12434158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.